Study of use of pain-killers, sedatives and agents used to paralyze patients in the pediatric intensive care unit
- Registration Number
- CTRI/2020/02/023610
- Lead Sponsor
- I
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 190
1.All patients in the age group > 1 month to 12 years who are newly admitted to the PICU and treated with either of analgesics, sedatives or neuromuscular blocking agents (either singly or in combination), will be included in the study.
2.Readmission of the same patient to PICU will be counted as a separate case enrolled.
3.Only the patients whose parents / legally acceptable representatives give written informed consent will be included.
Exclusion Criteria:
1.Pre-existing Patients in the PICU.
2.Patients who die within 24 hours of PICU stay. These patients will be excluded as we wish to calculate the daily total dose of the drugs used which will not be possible when the patients die within 24 hours of PICU stay.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method